Live Therapeutic Goods Administration News with Latest Updates

Live Therapeutic Goods Administration news and developments with the latest updates. Check out current Therapeutic Goods Administration news stories and find out what happened, what is going on with Therapeutic Goods Administration. Recent news updates about Therapeutic Goods Administration
AstraZeneca ChAdOx1–19 vaccine 16 April
Department of Health statement
Medsafe seeks additional Janssen COVID-19 vaccine data
AMA calls for clarity on vaccine rollout
Communication key on changing vaccine advice
Chief Health Officer statement: Adverse reaction linked to AstraZeneca vaccine
What is Novavax, Australia’s third COVID vaccine option?
2021 seasonal influenza vaccines
AstraZeneca ChAdOx1–19 vaccine 13 April
Qld company’s 15-min rapid Covid-19 test takes fight to Europe
Time for calm and clear information on vaccine rollout
Communication key to vaccine confidence
Chief Health Officer statement: AstraZeneca vaccine 8 April
Australia updates AstraZeneca safety advisory
Unlike UK, Australia has no other vaccine for young people
Wider storage and transportation conditions for Pfizer COVID-19 vaccine now approved
TGA to review advertising of stem cell therapies to Australian public
LIFEPAK CR2 Defibrillator
Chief Health Officer statement: AstraZeneca vaccine
ATAGI statement on COVID-19 vaccination and a reported case of thrombosis
Acting Chief Medical Officer and Head of TGA issue statement
ATAGI statement for consumers on a specific clotting condition being reported after COVID-19 vaccination
Australia TGA on specific clotting after COVID-19 vaccine
Top 3 COVID-19 vaccine questions – Long weekend safety, vaccine side effects and who to talk to
Bulk Buys Pty Ltd fined $13,320 for alleged unlawful importation of surgical face masks
ETU Statement on COVID-19 Vaccination
Emyria and Cann Group to partner on Schedule 3 medicine CBD product registration
Locally-made vaccine gets TGA approval
Melbourne-made COVID-19 vaccine now available
Medicinal cannabis to manage chronic pain?
Second phase of Australia’s COVID vaccine rollout is underway, despite a rocky start
COVID vaccination program needs community to be patient and well-informed
TGA approves CSL – Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia
ATAGI statement on AstraZeneca COVID-19 vaccine following European Medicines Agency safety review
AstraZeneca ChAdOx1–19 vaccine 19 March
Pharmacy fined $13,320 for alleged unlawful advertising
Anaphylactic reactions to COVID-19 vaccines in Western Australia
AstraZeneca ChAdOx1–19
COVID-19 vaccine roll out continues for Epworth frontline employees
Chief Health Officer advice: AstraZeneca vaccine rollout
Improvements to Tasmania’s Controlled Access Scheme for medicinal cannabis
Data suggest no increased risk of blood clots from AstraZeneca vaccine
Approval of updated storage conditions for Pfizer COVID-19 vaccine
AstraZeneca ChAdOx1–19 vaccine
Giving, receiving, sharing – advice for healthcare workers
AstraZeneca vaccine better when given 12 weeks apart
Opioid script changes mean well, but have left some people in chronic pain
COVID-19 vaccines – safety and effectiveness in older adults